The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Presentation opportunity in Japan and Korea.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.
P&G Ventures is looking for solutions to help men age with vitality and live their fullest lives.
The annual MIT Startup Ecosystem Conference features 25 of the most promising startups from across MIT. These startups are all part of STEX25, an accelerator run by MIT Startup Exchange, an integrated program of MIT Corporate Relations. The conference is the MIT Startup Exchange flagship event, and is a must-attend for executives at industry-leading corporations, especially for those who work in innovation, emerging technology, corporate venture capital, and/or corporate development/strategy.
Matthew Osman, Legit
Elbit America, a fast-growing defense company, is seeking technology partnership with startups in digital transformation, sonar / acoustics, HSA/DM, sensors, augmented reality, artificial intelligence / machine learning, optics, non GPS dependent precision north finding & non GPS dependent precision navigation and timing, precision Line of Sight (LOS) sensing, optical communications, and advanced video and image processing.